Варфарин 2,5 мг таблетки

Country: Kyrgyzstan

Bahasa: Rusia

Sumber: Правительства Кыргызской Республики (Департамент лекарственного обеспечения и медицинской техники)

Bahan aktif:

Варфарин

Boleh didapati daripada:

РУП "Белмедпрепараты"

Kod ATC:

B01AA03

INN (Nama Antarabangsa):

Warfarin

Dos:

2,5 мг

Borang farmaseutikal:

таблетки

Unit dalam pakej:

№100

Jenis preskripsi:

по рецепту

Dikeluarkan oleh:

РУП "Белмедпрепараты" (Беларусь)

Kawasan terapeutik:

Антикоагулянт непрямого действия

Ringkasan produk:

ПЖВЛС: нет

Tarikh kebenaran:

2016-06-23

Ciri produk

YTBEPxtNAIO
I{HCTPyKIIUq
rIO
MEAT
IqI,IHCKOMy
fIPI,IMEH
CPENCTBA
APCTBEHHOIO
BAPOAPI,IH
Topronoe
Ha3BaHne:
Bap$aprEH.
Mex4yHapoAHoe
HerrareHToB
aHHoe
Ha3B
aHrre
: BapQapzn
(warfarin).
JlercapcrneHHaq
Qopvra:
ra6leucu
2,5 xt.
Onncanue:
ra6lerxz
6eloro
IIBera
c nrocrofi
noBepxHocrbro
c
pucxoft
u
Sacxofi.
cocrae
Ha
oAHy
ra6.nerrcy:
deilcmeynuqee
6eu4ecmeo
-
nap$apvH
Harplfl
(e
elale
nap$apuHa
Harpprfl
rnarpara)
-
2,5
Mt
7cnoMozamenbHbte
seu4ecm6ai
nalTo3a
MoHofr4Apar,
K[urbrllat
rurApo$oc$an
rurrrrpar,
KpaxMaJr
xapro(femHrrfi,
[onu4ou
K-25,
MarHr.rq
creapar.
@apnrarcoreparleBTlrqecKas
rpyflfla
: AnrzxoarynrHT
Hertpqlroro
Aefi
c
rBvrfl,.
Koa
ATX:
B0IAA03
@apnrarcolorr.rqecKr{e
csofi
crsa
@ap*tarcoduHatvltKa
BapSapuu
6noru.rpyer
B
rerleHu
cr4HTe3
BrrraMr4H
K-saBrac[Mrx
Qarcropon
cBeprbrBaur4rr
KpoBr{,
a
LIMeHHo,
Qarcropa
II,
VII,
D( u X.
EcrnI
rorueHrpau[r
orr.rx
KoMrroHeHToB
B
KpoBr{
cHr4x{aercr,
To
npollecc
cBeprblBaeMocrl,I
-
3aMeArsercs.
Ha.Iaro
nport4BocBeprbrBaroUero
Aeftcrsur
na6mo4aerca
vepes
36
-72'nca
or HasaJIa
npleMa
rrpenapar4
c
pa3BLrrr4eM
MaKcr,rMrrrrbnoro
esserraua
5-7
1eas
or
HaqaJIa
rIpI{MeHeHI,It.
flocle
npeKpalrleHut
rrpvrevra
rlpenapara
BoccraHoBJleHr4e
aKTr4BHocrt4
BLITaMI,IH
K-sasLIcI4Msx
SarropoB
cBeprbrBzurlrr
KpoBr,r
npor{cxo.4r.rr
B Ter{eHr{e
4-5
4rreit.
QapuarcorcuHemLRa
flpenapar
6rtcrpo
BcacblBaercfl.
u3
xenyAorrHo-Kr4rrrerrHoro
rpaKTa.
CesgrreaHue
c 6erxarrau
rJIa3MbI
KpoBI4
cocraBJlter
97-99
%o.
Mera1ona3lrpyercs
B neqeHn.
Bap$apr.rH
rrpeAcraBJr-fler
co6ofi
paueMI4rIecKyio
cMecb,
np[rreM
R-
u
S- Lr3oMepbr
rraera6olagupyrorcs
B
leqeHr.r
pa3nvr{HbIMI'I
rlyrsMt4.
KaxArtfi
pI3
L3oMepon
upeo6pa3yercfl,
e
2
ocHosnrrx
uera6oJruTa.
OcuoeHrrNa
KaraJll{3aropor,t
ltera6oJrr.r3Ma
4rr
S-sHaurr.roMep
napSapana
rBJuercfl
(feprraeur
CYPZC9,
a
rnfl'
R-sHaHruorraep
nap$apzua
CYPIA2
u CYP3A4.
Jlenonparuatoutufrcsrr3oMep
eap$apana
(S-euanruovrep)
o6ra4aer
B 2-5
pas
6oruurefr
aHrr4KoaryrqHrHofi
aKrr4BHocrblo,
qeM
npaBoBpaqarorquficr
I43oMep
(R-eHaurnolaep),
oAHaKo,
trepr4oA
nonyBbrBeAeHrd.s
nocneAHefo
6olsu